Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report

B. Koletzko, R. Uauy, A. Palou, F.J. Kok, G. Hornstra, A. Eilander, D. Moretti, S.J.M. Osendarp, P.L. Zock, S. Innis

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)

Abstract

There is controversy whether children should have a dietary supply of preformed long-chain polyunsaturated n-3 fatty acids EPA and DHA. The aims of the workshop were to review evidence for a possible benefit of a preformed EPA and/or DHA supply, of data required to set desirable intakes for children aged 2–12 years, and of research priorities. The authors concluded that EPA and DHA intakes per kg body weight may often be low in 2- to 12-year-old children, relative to intakes per kg body weight of breast-fed infants and adult intakes, but reliable data are scarce. Little information is available that increasing dietary intakes of EPA or DHA in children has benefits to physical or mental function or other health endpoints. Studies addressing EPA and DHA intakes and tissue status among groups of children with different dietary habits, and measures of relevant development and health endpoints, are needed for developing potential advice on desirable intakes of EPA and/or DHA in children. At this time it appears prudent to advise that dietary intakes in childhood are consistent with future eating patterns supporting adult health, such as prevention of metabolic disorders and CVD, supporting immune function, and reproductive health. In conclusion, the available information relating dietary EPA and DHA intakes in children aged 2–12 years to growth, development and health is insufficient to derive dietary intake recommendations for EPA and DHA. Adequately designed studies addressing dietary intakes, measures of status and relevant functional or health effects across this age group are needed.
Original languageEnglish
Pages (from-to)923-928
JournalBritish Journal of Nutrition
Volume103
Issue number6
DOIs
Publication statusPublished - 2010

Fingerprint

Eicosapentaenoic Acid
Docosahexaenoic Acids
Education
Health
Body Weight
Reproductive Health
Omega-3 Fatty Acids
Feeding Behavior
Growth and Development
Breast
Age Groups
Eating
Research

Keywords

  • polyunsaturated fatty-acids
  • fish-oil supplementation
  • attention-deficit/hyperactivity disorder
  • randomized controlled-trials
  • double-blind
  • pregnancy outcomes
  • current knowledge
  • risk pregnancies
  • growth measures
  • food sources

Cite this

Koletzko, B. ; Uauy, R. ; Palou, A. ; Kok, F.J. ; Hornstra, G. ; Eilander, A. ; Moretti, D. ; Osendarp, S.J.M. ; Zock, P.L. ; Innis, S. / Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report. In: British Journal of Nutrition. 2010 ; Vol. 103, No. 6. pp. 923-928.
@article{5fadafd6dff944209eb3590f67d097ae,
title = "Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report",
abstract = "There is controversy whether children should have a dietary supply of preformed long-chain polyunsaturated n-3 fatty acids EPA and DHA. The aims of the workshop were to review evidence for a possible benefit of a preformed EPA and/or DHA supply, of data required to set desirable intakes for children aged 2–12 years, and of research priorities. The authors concluded that EPA and DHA intakes per kg body weight may often be low in 2- to 12-year-old children, relative to intakes per kg body weight of breast-fed infants and adult intakes, but reliable data are scarce. Little information is available that increasing dietary intakes of EPA or DHA in children has benefits to physical or mental function or other health endpoints. Studies addressing EPA and DHA intakes and tissue status among groups of children with different dietary habits, and measures of relevant development and health endpoints, are needed for developing potential advice on desirable intakes of EPA and/or DHA in children. At this time it appears prudent to advise that dietary intakes in childhood are consistent with future eating patterns supporting adult health, such as prevention of metabolic disorders and CVD, supporting immune function, and reproductive health. In conclusion, the available information relating dietary EPA and DHA intakes in children aged 2–12 years to growth, development and health is insufficient to derive dietary intake recommendations for EPA and DHA. Adequately designed studies addressing dietary intakes, measures of status and relevant functional or health effects across this age group are needed.",
keywords = "polyunsaturated fatty-acids, fish-oil supplementation, attention-deficit/hyperactivity disorder, randomized controlled-trials, double-blind, pregnancy outcomes, current knowledge, risk pregnancies, growth measures, food sources",
author = "B. Koletzko and R. Uauy and A. Palou and F.J. Kok and G. Hornstra and A. Eilander and D. Moretti and S.J.M. Osendarp and P.L. Zock and S. Innis",
year = "2010",
doi = "10.1017/S0007114509991851",
language = "English",
volume = "103",
pages = "923--928",
journal = "The British journal of nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "6",

}

Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report. / Koletzko, B.; Uauy, R.; Palou, A.; Kok, F.J.; Hornstra, G.; Eilander, A.; Moretti, D.; Osendarp, S.J.M.; Zock, P.L.; Innis, S.

In: British Journal of Nutrition, Vol. 103, No. 6, 2010, p. 923-928.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report

AU - Koletzko, B.

AU - Uauy, R.

AU - Palou, A.

AU - Kok, F.J.

AU - Hornstra, G.

AU - Eilander, A.

AU - Moretti, D.

AU - Osendarp, S.J.M.

AU - Zock, P.L.

AU - Innis, S.

PY - 2010

Y1 - 2010

N2 - There is controversy whether children should have a dietary supply of preformed long-chain polyunsaturated n-3 fatty acids EPA and DHA. The aims of the workshop were to review evidence for a possible benefit of a preformed EPA and/or DHA supply, of data required to set desirable intakes for children aged 2–12 years, and of research priorities. The authors concluded that EPA and DHA intakes per kg body weight may often be low in 2- to 12-year-old children, relative to intakes per kg body weight of breast-fed infants and adult intakes, but reliable data are scarce. Little information is available that increasing dietary intakes of EPA or DHA in children has benefits to physical or mental function or other health endpoints. Studies addressing EPA and DHA intakes and tissue status among groups of children with different dietary habits, and measures of relevant development and health endpoints, are needed for developing potential advice on desirable intakes of EPA and/or DHA in children. At this time it appears prudent to advise that dietary intakes in childhood are consistent with future eating patterns supporting adult health, such as prevention of metabolic disorders and CVD, supporting immune function, and reproductive health. In conclusion, the available information relating dietary EPA and DHA intakes in children aged 2–12 years to growth, development and health is insufficient to derive dietary intake recommendations for EPA and DHA. Adequately designed studies addressing dietary intakes, measures of status and relevant functional or health effects across this age group are needed.

AB - There is controversy whether children should have a dietary supply of preformed long-chain polyunsaturated n-3 fatty acids EPA and DHA. The aims of the workshop were to review evidence for a possible benefit of a preformed EPA and/or DHA supply, of data required to set desirable intakes for children aged 2–12 years, and of research priorities. The authors concluded that EPA and DHA intakes per kg body weight may often be low in 2- to 12-year-old children, relative to intakes per kg body weight of breast-fed infants and adult intakes, but reliable data are scarce. Little information is available that increasing dietary intakes of EPA or DHA in children has benefits to physical or mental function or other health endpoints. Studies addressing EPA and DHA intakes and tissue status among groups of children with different dietary habits, and measures of relevant development and health endpoints, are needed for developing potential advice on desirable intakes of EPA and/or DHA in children. At this time it appears prudent to advise that dietary intakes in childhood are consistent with future eating patterns supporting adult health, such as prevention of metabolic disorders and CVD, supporting immune function, and reproductive health. In conclusion, the available information relating dietary EPA and DHA intakes in children aged 2–12 years to growth, development and health is insufficient to derive dietary intake recommendations for EPA and DHA. Adequately designed studies addressing dietary intakes, measures of status and relevant functional or health effects across this age group are needed.

KW - polyunsaturated fatty-acids

KW - fish-oil supplementation

KW - attention-deficit/hyperactivity disorder

KW - randomized controlled-trials

KW - double-blind

KW - pregnancy outcomes

KW - current knowledge

KW - risk pregnancies

KW - growth measures

KW - food sources

U2 - 10.1017/S0007114509991851

DO - 10.1017/S0007114509991851

M3 - Article

VL - 103

SP - 923

EP - 928

JO - The British journal of nutrition

JF - The British journal of nutrition

SN - 0007-1145

IS - 6

ER -